GenapSys Raises $8.5M of Targeted $13.6M | GenomeWeb

NEW YORK (GenomeWeb News) – DNA sequencing technologies startup GenapSys has raised $8.5 million of a target goal of $13.6 million, the company disclosed in a document recently filed with the US Securities and Exchange Commission.

The company said in its Form D that the amount raised is in the form of equity, and 11 investors participated in the raise.

Hesaam Esfandyarpour, GenapSys' founder and CEO, did not respond to requests seeking comment and it is unclear who the participants are in the private financing round. It also is unclear how the funds will be used.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.